Sophie Morse is a Hematologist Oncology specialist and a Hematologist in Summit, New Jersey. Dr. Morse is highly rated in 31 conditions, according to our data. Her top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Familial Pancreatic Cancer.

Alice Cohen is a Hematologist in Livingston, New Jersey. Dr. Cohen is highly rated in 20 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Hemophilia A, and Hemophilia B.

Jeffrey Jones is a Hematologist Oncology provider in Summit, New Jersey. Dr. Jones is highly rated in 7 conditions, according to our data. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Leukemia, and Bone Marrow Aspiration.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is highly rated in 32 conditions, according to our data. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is highly rated in 25 conditions, according to our data. His top areas of expertise are Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

With his many speaking engagements and commitment to education, Dr. Neil Morganstein has a reputation as a leader in the treatment of hematological and oncological issues. He is a national speaker in the area of multiple myeloma, as well as co-chair of a video conference on the management of patients with multiple myeloma. He has a special interest in lung cancer and multiple myeloma, and has published and presented several peer-reviewed articles, posters and abstracts at regional and national oncology meetings. These have focused on multiple myeloma, lymphoma, prostate cancer, gastric cancer, and hematological complications during pregnancy.As an involved and committed oncologist at Overlook Medical Center’s Carol G. Simon Cancer Center, Dr. Morganstein gives several lectures a year educating medical students. He teaches the hematology board review course for the American College of Physicians, as well as the hematology and oncology course for residents at Rutgers University. In addition, he thoroughly enjoys working with medical students in the hospital.Dr. Morganstein completed his hematology and oncology fellowship at Robert Wood Johnson University Hospital of New Brunswick, New Jersey, where he also finished his residency training, while serving as chief resident. He is board-certified in medical oncology, hematology and internal medicine and maintains membership in many distinguished organizations, including the American Society of Clinical Oncologists and the American Society of Hematologists. Dr. Morganstein is highly rated in 23 conditions, according to our data. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration.

Usman Shah is a Hematologist and an Oncologist in Summit, New Jersey. Dr. Shah is highly rated in 22 conditions, according to our data. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Shah is currently accepting new patients.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is highly rated in 18 conditions, according to our data. Her top areas of expertise are Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS).

Dr. Dennis Lowenthal has dedicated his career to caring for cancer patients, particularly those with lung cancer. He is the medical director of Medical Diagnostics Associates Hematology and Oncology, which is part of the Atlantic Medical Group. He also serves as medical director of Atlantic Health System’s Carol G. Simon Cancer Center at Overlook Medical Center.Growing up in the Bronx, NY, Dr. Lowenthal attended the State University of New York at Buffalo where he graduated magna cum laude with a BA in biology. He earned his medical degree at Boston University School of Medicine, continued with a medical internship at the Cleveland Clinic, and returned to the Bronx to complete his medical residency and a hematology fellowship at Montefiore Hospital and Medical Center of the Albert Einstein College of Medicine. He subsequently completed a clinical Blood Bank Directors fellowship at the New York Blood Center and then went on to complete a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center where he served as Chief Fellow and Special Clinical Fellow in AIDS-related malignancies.Dr. Lowenthal considers coming to Overlook Medical Center 32 years ago one of his best life decisions, working with his colleagues to help create the Carol G. Simon Cancer Center at Overlook Medical Center. He serves as chairman of the hospital’s Cancer Committee and Cancer Center Executive Committee, and has been the long-standing section chief for Hematology/Oncology. He is co-chairman of Thoracic Oncology and the Thoracic Tumor Board at Atlantic Health System and is the principal investigator for lung cancer clinical trials conducted at Overlook Medical Center – specifically, serving as the principal investigator for the first immunotherapy approved for the treatment of lung cancer. Dr. Lowenthal is a past recipient of Overlook’s Physician Excellence in Clinical Practice award and has been an associate professor of Clinical Medicine at Columbia University College of Physicians and Surgeons, Mount Sinai School of Medicine, and currently the Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Lowenthal is highly rated in 17 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is highly rated in 16 conditions, according to our data. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration.

Beaula Koduri is a Hematologist and an Internal Medicine provider in Edison, New Jersey. Dr. Koduri is highly rated in 15 conditions, according to our data. Her top areas of expertise are Anemia, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Dehydration. Dr. Koduri is currently accepting new patients.

Dr. Saksena is a dynamic, clinically oriented, hematologist/oncologist with several years of experience in the treatment of various cancers and blood disorders. She is triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. Her strong medical back- ground combined with her passion to build meaningful patient-centered relationships enables her to deliver leading-edge care in a highly personalized manner. She practices comprehensive cancer care, with direct access to the latest clinical trials, and works closely with surgeons, radiation oncologists, genetic counselors, nurses, social workers and dietitians.Dr. Saksena attended Lehigh University, where she obtained a bachelor of science degree in behavioral neuroscience. She earned her medical degree at Jefferson Medical College, part of Thomas Jefferson University in Philadelphia, and then completed her hematology/oncology fellowship at Rutgers Cancer Institute of New Jersey (CINJ) & Robert Wood Johnson University Hospital in New Brunswick.During her education, Dr. Saksena received a number of honors, awards and scholarships for her clinical work, leadership roles, and research. She served as chief fellow of hematology oncology while at Rutgers CINJ, the state’s only National Cancer Institue-designated cancer center. Dr. Saksena also speaks Hindi, Gujarati and conversational Spanish, and is committed to community outreach through advocacy groups and as a liaison of the American Medical Women’s Association.Dr. Saksena is a member of Atlantic Medical Group, and is a participating provider in the Atlantic Accountable Care Organization. Dr. Saksena is highly rated in 14 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Primitive Neuroectodermal Tumor (PNET).

Heather Katz, DO, FACOI, FACP, is a board-certified hematologist and medical oncologist specializing in the diagnosis and treatment of solid tumors and hematologic malignancies. Her clinical expertise includes cancers of the breast, gastrointestinal tract, head and neck, genitourinary system, lung, and gynecologic organs, as well as hematologic conditions such as leukemia, lymphoma, and multiple myeloma. Dr. Katz is committed to delivering comprehensive, evidence-based care grounded in compassion and respect for each patient’s individual journey. She emphasizes shared decision-making, continuity of care, and clear communication to empower patients and their families throughout treatment and survivorship. Dr. Katz earned her Bachelor of Science in Biology, with a minor in Human Development, from the State University of New York at Geneseo. She received her medical degree from Rocky Vista University College of Osteopathic Medicine in Parker, Colorado, and completed her internal medicine residency at Broward Health Medical Center in Fort Lauderdale, Florida, where she served as Chief Resident and was named Resident of the Year. She went on to complete her fellowship in Hematology and Medical Oncology at Marshall University’s Joan C. Edwards School of Medicine in Huntington, West Virginia, serving as Chief Fellow in her final year. Board certified in Internal Medicine, Medical Oncology, and Hematology by the American Osteopathic Board of Internal Medicine, Dr. Katz is a Fellow of both the American College of Osteopathic Internists and the American College of Physicians. She has presented at numerousnational oncology conferences and is the author of over 15 peer-reviewed publications in the medical literature. Dr. Katz is dedicated not only to clinical excellence but also to advancing the field of oncology through research, education, and mentorship. Her patients recognize her for her thoughtful bedside manner, personalized treatment planning, and unwavering commitment to high-quality care. . Dr. Katz is highly rated in 12 conditions, according to our data. Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Salpingo-Oophorectomy.

"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is highly rated in 12 conditions, according to our data. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer.

Dr. Manish J. Dave is the Director of Blood Disorders and Hematologic Malignancies for the Hackensack Meridian Health Central Region. He is an experienced, full-time physician who is triple board-certified in internal medicine, hematology, and medical oncology. Dr. Dave sees patients at JFK University Medical Center. He has a strong academic foundation and treats patients with a variety of conditions related to malignant hematology, solid oncology, and benign hematology. His career opportunities have allowed him to present numerous cases at weekly tumor boards and serve as principal investigator for clinical trials. Dr. Dave is involved with clinical research (focused on malignant hematology) and he has a multitude of peer-reviewed publications. He is actively involved in teaching medical students and housestaff through clinical rotations, serving as a preceptor, and presenting PowerPoints at Journal Club, Morning Report, and Noon Conferences. He has held a number of leadership roles in the past. He was the Resident Representative of the Cancer Committee at Rush University Medical Center, Hematology Chief Fellow at Albert Einstein College of Medicine, and he served as the Chair of the Blood Transfusion Committee at Putnam Hospital. Dr. Dave served on the Cold Agglutinin Advisory Board for Sanofi Pharmaceuticals, and he is currently on the Speaker Bureau for Sanofi and Merck. He has presented his clinical and basic science research at renowned national research conferences (including the ASCO and ACP annual meetings). He has been a clinical speaker for Reblozyl at Bristol Myers Squibb. Dr. Dave has been a speaker at a multitude of national medical conferences. Dr. Dave's philosophy is to treat every patient as he would treat his own family member. He strives to provide the best and newest available therapies for his patients. He has extensive experience in procedural skills, including bone marrow aspirates and biopsies and peripheral smear review. Dr. Dave has received multiple awards for superb patient feedback and outstanding clinical skills. He received the Milli Award in 2017 and Top Hematology & Oncology Physician Award in 2018 and 2024. He has volunteered and helped to coordinate medical care for the underserved in Winston-Salem, NC (through the DEAC Clinic and “Share the Health” Fair) and through an overseas medical mission trip (Child Family Health International) in Mumbai. Dr. Dave has had the privilege of working with a multi-disciplinary team in caring for cancer patients, and he strives to deliver the best evidence-based care possible. Dr. Dave is highly rated in 12 conditions, according to our data. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, Pulmonary Embolism, and Bone Marrow Aspiration.

Dr. Markowski has been contributing to the field of oncology since working in a cancer research lab during and after his undergraduate work at Johns Hopkins University. A desire to care for patients brought him back to his home state of New Jersey where he completed his medical school degree at Rutgers-Robert Wood Johnson Hospital in New Brunswick, NJ. He then completed internal medicine residency and subsequent hematology/oncology fellowship training at Rutgers-Robert Wood Johnson Hospital/Cancer Institute of New Jersey.Throughout his hematology and oncology career Dr Markowski has published and presented many peer-reviewed articles, abstracts, and posters on a multitude of cancer types. He has particular interest and expertise in lung cancer, gastrointestinal cancers, and breast cancer. In addition, he has extensive experience taking care of patients with both benign and malignant blood disorders. Dr. Markowski is highly rated in 10 conditions, according to our data. His top areas of expertise are Thrombocytopenia, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Bone Marrow Aspiration.

Matthew Stuart, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Dr. Stuart’s clinical interests include colorectal, pancreatic, gastrointestinal, lung, urological (GU) cancer, hematology, anemia, clotting disorders, lymphoma, multiple myeloma, and preventative care.Board-certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine, Dr. Stuart believes in treating the patient as a whole, implementing evidence-based, patient-centered, and cost-conscious care. His recent research includes evaluating race-based differences in treatment complications in patients with metastatic prostate cancer, improving vaccination rates in patients receiving chemotherapy, and providing community outreach to increase lung cancer screening and early detection.Dr. Stuart earned his medical degree at Rutgers New Jersey Medical School, Newark, NJ, where he served as director of the Student Family Health Care Center, the mini-medical school and premedical honors program, and the Institute for Public Understanding of Medicine in Action. He performed his internal medicine residency at Montefiore Medical Center, Bronx, NY, where he served on the Emergency-Internal Medicine and Resident Recruitment committees and received the Leo M. Davidoff Society Award for outstanding achievement in the teaching of medical students and a program innovation and improvement award. He remained at Montefiore to complete a fellowship in hematology/oncology, where he was named the chief hematology fellow and served on the Program Evaluation Committee. Following his fellowship training, he joined ACOHA in 2020.Fluent in conversational Spanish, Dr Stuart has presented at national and international medical conferences. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Stuart is highly rated in 4 conditions, according to our data. His top areas of expertise are Childhood Iron Deficiency Anemia, Colorectal Cancer, Familial Colorectal Cancer, Iron Deficiency Anemia, and Bone Marrow Aspiration.

Dr. Bonni Lee Guerin is a hematologist/oncologist and director of the Breast Cancer Treatment and Prevention Program at Overlook Medical Center, Summit, NJ where she also serves as chair of the Breast Panel, the Multidisciplinary Breast Tumor Board and director of Oncology Education. She is the principal investigator of numerous clinical trials exploring new ways to incorporate the latest advances in the management of breast cancer. She is also actively involved in the delivery of highly-specialized immunotherapy, IL-2, for the treatment of melanoma and kidney cancer.As a medical oncologist with more than 20 years of experience, Dr. Guerin is dedicated to providing the most up to date, cutting edge treatment while looking at each of her patients as an individual. Her philosophy is one of collaboration, working with all members of the care team to provide the best outcome possible. Dr. Guerin believes that compassion and being a good listener, traits she learned from her mother, help tailor a treatment plan that reflects not only the highest order of medical care, but also one that uniquely reflects each and every patient. Dr. Guerin believes it is just as much about living well as it is living long.Dr. Guerin earned her M.D. at SUNY Stonybrook in 1988, continued her residency at Vanderbilt University in Nashville and completed her fellowship in oncology/hematology at University of California San Diego Cancer Center. She is board certified in clinical oncology and internal medicine.Since 2002, Dr. Guerin has served as chair of the Women’s Oncology Forum, Network for Oncology Communication and Research (NOCR) – a national organization. She is a diplomate of the American Society of Clinical Oncology (ASCO) and is a recipient of the Pfizer Award for Excellence in Biochemical Research and a Member of the Expert Panel Consensus Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma. She has been named by Castle Connelly as one of NY/Metro Top Doctors for the last 10 years, as well as a Top Doctor for Women's Health. She has recently been honored by Curemonos, a New Jersey non-profit organization dedicated to supporting medically underserved women with breast cancer, and was the keynote speaker at the American Cancer Society Relay for Life in Chatham, NJ. Her interests are in breast cancer, hepatobiliary cancer and immunotherapy. Dr. Guerin is highly rated in 4 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Israel Grossman is a Hematologist Oncology specialist and a Hematologist in Livingston, New Jersey. Dr. Grossman is highly rated in 54 conditions, according to our data. His top areas of expertise are Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Plasmacytoma, Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), and Bone Marrow Aspiration. Dr. Grossman is currently accepting new patients.

Said Saleh is a Hematologist in West Orange, New Jersey. Dr. Saleh is highly rated in 31 conditions, according to our data. His top areas of expertise are Iron Deficiency Anemia, Thrombocytopenia, Childhood Iron Deficiency Anemia, Anemia, and Endoscopy.

James Orsini is a Hematologist in West Orange, New Jersey. Dr. Orsini is highly rated in 29 conditions, according to our data. His top areas of expertise are Lung Cancer, Colorectal Cancer, Iron Deficiency Anemia, Familial Prostate Cancer, and Bone Marrow Aspiration.

Stuart Leitner is a Hematologist Oncology specialist and a Hematologist in Livingston, New Jersey. Dr. Leitner is highly rated in 28 conditions, according to our data. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Leitner is currently accepting new patients.

Louise Ligresti is a Hematologist Oncology specialist and an Oncologist in Livingston, New Jersey. Dr. Ligresti is highly rated in 16 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma. Dr. Ligresti is currently accepting new patients.

Michael Scoppetuolo is a Hematologist Oncology specialist and an Oncologist in Livingston, New Jersey. Dr. Scoppetuolo is highly rated in 16 conditions, according to our data. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Scoppetuolo is currently accepting new patients.

Adrienne Phillips is a Hematologist Oncology specialist and an Oncologist in Livingston, New Jersey. Dr. Phillips is highly rated in 15 conditions, according to our data. Her top areas of expertise are Adult T-Cell Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.